Machinery News

  • Industrial Ice Cream Solution Provider

    Fu Chen Technology - Industrial Ice Cream Solution Provider

    This is a recently completed project by Fu Chen Technology. The content of the project includes full-automatic popsicle and ice cream plant equipment, and the production mode is fully automatic production, and is equipped with a C.I.P positioning cleaning system, so that production and cleaning are automatically completed in the pipeline, in line with standard procedures, and can greatly reduce labor costs, achieve the best benefit.           More

    Industry News

  • NI Protocol: Medicine Supply Still Faces 'Significant Issue'

    There are still unresolved issues with the Northern Ireland Protocol despite changes made by the EU, says a major pharmaceutical firm.   Earlier this year, the EU altered its laws in a move aimed at guaranteeing the supply of medicines from Great Britain to Northern Ireland. However, Teva says there is still one "very significant" issue related to the continued supply of some drugs. The firm has raised the matter in a consultation on the NI Protocol Bill. The protocol is the post-Brexit trading deal agreed by the UK and the EU in 2019. The UK plans to use the Protocol Bill to override most of the agreement if the EU does not agree to changes.   What is the problematic issue?   The protocol means Northern Ireland is still inside the EU's pharmaceutical regulatory system. However, it gets most of its medicines from Great Britain, which is not. This emerged as one of the protocol's major difficulties, with pharmaceutical firms warning it would lead to withdrawal of products.   The EU accepted it was a problem and in April changed its laws so that medicines entering NI from GB will not need additional labelling or testing, things which would have been required by the protocol in its original form.   What is the Northern Ireland Protocol? Businesses question government's protocol plans   Teva says this removed the "most onerous regulatory burdens arising from the protocol" and allowed it to continue supplying medicines to NI without additional complexities. The firm says the current problematic issue is the treatment of so-called Centralised Procedure (CP) product licences. It says that in order to continue to supply products approved via the CP route in NI, an EU authorisation is required, so a company needs to have two different product licences, one covering GB and one covering NI.   The firm adds that it has been clear that any situation that leads to the need for two product licences "creates an administrative and cost burden that will make many medicines unviable to supply to NI". Teva currently supplies about 630 products to NI, 48 of which have CP licences. It says it believes the full impact of the CP issue is yet to be seen and it will be making decisions based on current market share and historical sales.   'A very complex situation'   Separately, a body which represents businesses providing over-the-counter medicines has also raised the CP issue. The PAGB says a way needs to be found to ensure medicines licenced via the CP route can be sold in both GB and NI as a single pack, without divergence in the licences behind them. Like Teva the PAGB says the issue "can and should be resolved via negotiations". Meanwhile, concerns have also been raised about how the government's replacement plan for the protocol would work in respect of medicines.   Part of the government's plan is for a dual regulatory regime, which would mean goods made to either EU or UK standard could be sold in Northern Ireland. Teva said that "in theory" it could be supportive of a dual regulatory regime as it should allow UK-wide licencing. However, in its view for a dual regime to be attainable, there "could be no divergence between UK and EU regulations. As soon as there is any divergence then this becomes extremely problematic". Asked about negotiations over the protocol on Wednesday, Sinn Féin vice-president Michelle O'Neill urged the UK and the EU to "get on with it".   Meanwhile the Nuffield Trust, a health think tank, says the dual regime would "create a very complex situation". "Pharmacists and doctors would be prescribing and dispensing drugs approved and tested under two different systems, with different mechanisms for detecting falsified medicines," it added. More

    Exhibition News

  • 2023 IPPE Attendee Registration and Housing Opens Oct. 3

    Attendee registration and general housing for the 2023 International Production & Processing Expo (IPPE) opens Monday, Oct. 3.   With more than 515,000 square feet of exhibit space and 1,015-plus exhibitors, the IPPE trade show floor continues to grow with four months remaining until to the Expo. Be sure to register online to receive a discounted price of $75 (USD) through Jan. 6, 2023. Beginning Jan. 7, the registration rate is $125. “We look forward to welcoming our domestic and international attendees to the 2023 IPPE! There is nothing like meeting face-to-face to experience all that IPPE offers in innovation, networking and learning opportunities,” remarked IPPE show management. The 2023 IPPE will provide a full week to see and experience the newest technology in the industry, participate in events on the show floor and network with key leaders from the animal food, meat, and poultry and egg industries. The vast trade show floor will showcase the most current innovations, equipment and services used in the production and processing of animal food, meat, and poultry and egg products. Combining the expertise from the American Feed Industry Association, North American Meat Institute and U.S. Poultry & Egg Association, IPPE will also feature countless hours of dynamic education sessions focused on the latest industry issues.   Through Jan. 6, the “Members to Atlanta” (M2A) program waives the registration fee for qualified attendees from member companies of all three associations engaged in the production of poultry, eggs and meat for consumption, production of feed, and for pet food manufacturers. The program is supported through the sponsorship of elite IPPE exhibitors, which include Aviagen, CEVA Animal Health, Cobb-Vantress, Inc., Elanco Animal Health, Georgia Poultry Equipment Co., Heat and Control, Huvepharma, Jamesway Chick Master Incubator Inc., Kemin Industries, Inc., Soybean Meal Information Center and Zoetis. “We sincerely appreciate and thank these elite exhibiting companies for participating in and supporting the M2A program. The program continues to deliver results in increasing attendance and contributing to the success of IPPE,” said IPPE show management.     For more information and to register for the 2023 IPPE, visit www.ippexpo.org.   About IPPE   The International Production & Processing Expo (IPPE) is a collaboration of three shows - International Feed Expo, International Meat Expo and the International Poultry Expo - representing the entire chain of protein production and processing. The event is sponsored by the American Feed Industry Association (AFIA), North American Meat Institute (NAMI) and U.S. Poultry & Egg Association (USPOULTRY).   About AFIA   Founded in 1909, the American Feed Industry Association (AFIA), based in Arlington, Va., is the world's largest organization devoted exclusively to representing the business, legislative and regulatory interests of the U.S. animal food industry and its suppliers. The organization's membership is comprised of more than 650 domestic and international companies that represent the total feed industry-manufacturers of commercial and integrated feed and pet food, ingredient suppliers, pharmaceutical companies, industry support and equipment manufacturers. AFIA members manufacture more than 75% of the feed and 70% of the non-grain ingredients used in the country. AFIA is also recognized as the leader on international industry developments and holds membership in the International Feed Industry Federation (IFIF).   About NAMI   The North American Meat Institute (NAMI) is the leading voice for the meat and poultry industry. Formed from the 2015 merger of the American Meat Institute (AMI) and North American Meat Association (NAMA), the Institute has a rich, century-long history and provides essential member services including legislative, regulatory, scientific, international and public affairs representation. NAMI's mission is to shape a public policy environment in which the meat and poultry industry can produce wholesome products safely, efficiently and profitably. Together, the Institute's members produce the vast majority of U.S. beef, pork, lamb and poultry and the equipment, ingredients and services needed for the highest quality products.   About USPOULTRY   U.S. Poultry & Egg Association (USPOULTRY) is the All Feather Association progressively serving its poultry and egg members through research, education, communications and technical service. Founded in 1947, USPOULTRY is based in Tucker, Georgia. More

Exhibition Partner

Media Partner